Ross Stores (NASDAQ: ROST) had a really strong third quarter in 2023. The headline-grabbing number was 5% same-store sales growth. That was very good, but there are some nuances here. And while current shareholders should be pleased by the company's success, investors looking at
Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans.
It's quite easy to list the attributes that income investors love to see in a stock. Obviously, a juicy dividend yield is high on the list. A reliable payout ranks way up there, too. And while income is paramount, even dividend investors enjoy share-price appreciation.
Once upon a time, I was convinced that Elon Musk was a genius with a world-changing vision. I bought my first Tesla (NASDAQ: TSLA) shares in the summer of 2014, citing five unique company qualities. I liked the company's radical approach to research and development, the game-chan
Shiba Inu (CRYPTO: SHIB) is one of the most popular cryptocurrency tokens at the speculative end of the industry. In 2021 it delivered one of the greatest returns in financial market history; a perfectly timed investment of just $3 on Jan. 1 would have made you a millionaire by t
Global stocks edged up on Friday, having closed out their best month in three years the day before, as investor confidence that interest rates will fall next year has lured cash into equities, cryptocurrencies and gold at the expense of the dollar.
Gold prices were set for a third straight weekly gain after data showing easing inflation raised expectations that the U.S. Federal Reserve would soon start cutting interest rates, with Chair Jerome Powell's speech later on Friday in focus.
Shopify (NYSE: SHOP) stock is expensive right now. Shares of the barely profitable e-commerce outfit trade at 74 times next year's expected earnings. The company's pace of sales growth is slowing down, too, even if only because its past growth has made for tougher comparisons now
I'm going way off the beaten path to highlight two beaten-down growth stocks today. MKS Instruments (NASDAQ: MKSI) and Trex (NYSE: TREX) aren't household names by any means. But they each have a long history of growth and strong shareholder returns -- the present downturn notwith
Pakistan's Supreme Court began hearings on Friday on a petition by rights activists seeking to halt deportation of Afghan refugees, a lawyer said, as authorities are combing refugee settlements in an effort to find and send home thousands.
U.S. data is moving against the dollar, which could force the Fed to cut rates as markets expect, and next Friday's jobs report will play a key role in developing expectations.
AstraZeneca on Friday said it would discontinue two late-stage trials looking at the potential benefits of its drug Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.
The South Korean won and the Taiwan dollar started December on a weak note on Friday, after the U.S. dollar steadied on commentary from Federal Reserve officials which pushed back market expectations on a quick pivot to rate cuts.
(RTTNews) - AstraZeneca (AZN.L, AZN) said it has decided to discontinue the STABILIZE-CKD and DIALIZE-Outcomes Phase III evidence trials for Lokelma. The company said the decision was made due to substantially increased enrolment timelines and low event rates, respectively, which
British house prices rose unexpectedly in monthly terms for the third time running in November, adding to signs that the housing market downturn has abated, mortgage lender Nationwide said on Friday.
Brookfield said on Friday it would consider the implications of Australia's new green energy policy on Origin Energy before making a new offer should its $10.6 billion bid for the firm be voted down by the takeover target's shareholders on Monday.
Turkish factory activity contracted for a fifth consecutive month in November as purchasing activity moderated along with a slowdown in output, new orders and employment, a survey showed on Friday.
A boom in clean power electricity generation has helped push Europe's forward power prices to their lowest levels since before Russia's invasion of Ukraine in 2022 severed natural gas pipeline flows and sent the region's power prices surging.